These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9397147)

  • 21. [NSAID-induced gastropathies: problems and ways of their resolutions].
    Tkachenko EI; Uspenskiĭ IuP; Pakhomova IG
    Eksp Klin Gastroenterol; 2006; (6):41-8. PubMed ID: 17612095
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical symptoms, endoscopic findings and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions.
    Aabakken L
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S19-22. PubMed ID: 10379465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Lane ME; Kim MJ
    J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of non steroidal anti-inflammatory drug induced gastro-intestinal damage.
    McCormack PM
    Ir Med J; 1994; 87(2):27-8. PubMed ID: 8194941
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastropathy induced by nonsteroidal anti-inflammatory drugs (Part II)].
    Nasonov EL; Karateev AE
    Klin Med (Mosk); 2000; 78(4):4-9. PubMed ID: 10833880
    [No Abstract]   [Full Text] [Related]  

  • 27. Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract.
    Lanas A
    Aliment Pharmacol Ther; 2004 Aug; 20(3):321-31. PubMed ID: 15274669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Unsolved problems of enteropathy induced by nonsteroidal anti-inflammatory drugs].
    Murav'ev IuV; Lebedeva VV
    Ter Arkh; 2009; 81(2):90-3. PubMed ID: 19334501
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cost-effectiveness of misoprostol prevention].
    Larsson PO
    Lakartidningen; 1992 Oct; 89(44):3657. PubMed ID: 1460977
    [No Abstract]   [Full Text] [Related]  

  • 30. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastrointestinal damage in osteoarthritis patients].
    Fuller R; Hirose-Pastor E; Levy M; Zaterka S; Massuda HB; Eisig JN; Yoshinari NH
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):47-50. PubMed ID: 9435394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
    Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
    Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ulcers from NSAIDs can be prevented.
    Health News; 2004 Mar; 10(3):11. PubMed ID: 15017941
    [No Abstract]   [Full Text] [Related]  

  • 34. Review article: acid-related disease--what are the unmet clinical needs?
    Katz PO; Scheiman JM; Barkun AN
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():9-22. PubMed ID: 16700899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Enteropathy induced by nonsteroid anti-inflammatory drugs].
    Karateev AE; Nasonova VA
    Ter Arkh; 2004; 76(2):79-82. PubMed ID: 15106423
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-steroidal antiinflammatory drugs. A review.
    Winzeler S; Rosenstein BD
    AAOHN J; 1998 May; 46(5):253-9; quiz 260-1. PubMed ID: 9652239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Economic evaluation of the use of diclofenac/misoprostol in the treatment of osteoarticular diseases].
    Soto Alvarez J
    An Med Interna; 2000 Sep; 17(9):477-84. PubMed ID: 11100534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal tract disorder as a side effect of non-steroidal anti inflammatory drugs (NSAIDs).
    Simadibrata M
    Acta Med Indones; 2004; 36(4):195-6. PubMed ID: 15931719
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preventive therapy with H2 blockers in patients using steroids and nonsteroidal anti-inflammatory drugs].
    Abramovich D; Scapa E; Broide E; Eshchar J
    Harefuah; 1994 Mar; 126(5):271-3. PubMed ID: 7910573
    [No Abstract]   [Full Text] [Related]  

  • 40. NICE risk factors for gastrointestinal adverse events in diclofenac users in general practice in Germany: comment on the article of Thompson et al.
    Zeidler H; May M; Uberall MA; Vergin H
    Rheumatology (Oxford); 2006 Apr; 45(4):494-5. PubMed ID: 16484292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.